compound 1 [PMID: 21742770]   Click here for help

GtoPdb Ligand ID: 8190

Compound class: Synthetic organic
Comment: Compound 1 was identified as a potent inhibitor of serine/threonine kinase 33 (STK33) in a high-throughput screen of a compound library [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 67.16
Molecular weight 444.23
XLogP 4.74
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cc(ccc1N1CCN(CC1)C)Nc1ccc2c(n1)n(nc2)c1ccc(cc1)OC
Isomeric SMILES COc1cc(ccc1N1CCN(CC1)C)Nc1ccc2c(n1)n(nc2)c1ccc(cc1)OC
InChI InChI=1S/C25H28N6O2/c1-29-12-14-30(15-13-29)22-10-5-19(16-23(22)33-3)27-24-11-4-18-17-26-31(25(18)28-24)20-6-8-21(32-2)9-7-20/h4-11,16-17H,12-15H2,1-3H3,(H,27,28)
InChI Key LZQFMCFJCXQTTG-UHFFFAOYSA-N
References
1. Babij C, Zhang Y, Kurzeja RJ, Munzli A, Shehabeldin A, Fernando M, Quon K, Kassner PD, Ruefli-Brasse AA, Watson VJ et al.. (2011)
STK33 kinase activity is nonessential in KRAS-dependent cancer cells.
Cancer Res, 71 (17): 5818-26. [PMID:21742770]
2. Weïwer M, Spoonamore J, Wei J, Guichard B, Ross NT, Masson K, Silkworth W, Dandapani S, Palmer M, Scherer CA et al.. (2012)
A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells.
ACS Med Chem Lett, 3 (12): 1034-1038. [PMID:23256033]